Parallel Advisors’s Krystal Biotech KRYS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $256K | Buy |
1,863
+132
| +8% | +$18.1K | 0.01% | 900 |
|
|
2025
Q1 | $312K | Sell |
1,731
-1,506
| -47% | -$272K | 0.01% | 761 |
|
|
2024
Q4 | $507K | Hold |
3,237
| – | – | 0.01% | 571 |
|
|
2024
Q3 | $589K | Hold |
3,237
| – | – | 0.01% | 522 |
|
|
2024
Q2 | $594K | Sell |
3,237
-15
| -0.5% | -$2.76K | 0.02% | 484 |
|
|
2024
Q1 | $579K | Sell |
3,252
-794
| -20% | -$141K | 0.02% | 490 |
|
|
2023
Q4 | $502K | Sell |
4,046
-125
| -3% | -$15.5K | 0.01% | 486 |
|
|
2023
Q3 | $484K | Buy |
4,171
+53
| +1% | +$6.15K | 0.02% | 467 |
|
|
2023
Q2 | $483K | Sell |
4,118
-11,987
| -74% | -$1.41M | 0.02% | 479 |
|
|
2023
Q1 | $1.29M | Sell |
16,105
-17
| -0.1% | -$1.36K | 0.04% | 265 |
|
|
2022
Q4 | $1.28M | Sell |
16,122
-5,236
| -25% | -$415K | 0.06% | 223 |
|
|
2022
Q3 | $1.49M | Buy |
21,358
+74
| +0.3% | +$5.16K | 0.07% | 182 |
|
|
2022
Q2 | $1.4M | Sell |
21,284
-3,281
| -13% | -$216K | 0.06% | 188 |
|
|
2022
Q1 | $1.64M | Sell |
24,565
-9,471
| -28% | -$633K | 0.07% | 196 |
|
|
2021
Q4 | $2.38M | Buy |
34,036
+28,582
| +524% | +$2M | 0.09% | 150 |
|
|
2021
Q3 | $285K | Hold |
5,454
| – | – | 0.01% | 584 |
|
|
2021
Q2 | $371K | Hold |
5,454
| – | – | 0.02% | 472 |
|
|
2021
Q1 | $420K | Hold |
5,454
| – | – | 0.02% | 394 |
|
|
2020
Q4 | $327K | Hold |
5,454
| – | – | 0.02% | 428 |
|
|
2020
Q3 | $235K | Hold |
5,454
| – | – | 0.01% | 499 |
|
|
2020
Q2 | $225K | Buy |
+5,454
| New | +$225K | 0.01% | 503 |
|